Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Vazquez

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 7, 2013
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cellsSílvia Cufí, Rosa Bonavia, Alejandro Vazquez-Martin, et al.
The Journal of Biological Chemistry|July 9, 2003
Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1Fernand Gobeil, Sylvie G Bernier, Alejandro Vazquez-Tello, et al.
Circulation Research|April 6, 2002
Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptorsFernand Gobeil, Isabelle Dumont, Anne Marilise Marrache, et al.
International Journal of Oncology|August 12, 2011
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line modelsCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Bernardo Queralt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptorA Marilise Marrache, Fernand Gobeil, Sylvie G Bernier, et al.
Advances in Experimental Medicine and Biology|May 20, 2003
Platelet activating factor receptorsA Marilise Marrache, Fernand Gobeil, Sylvie G Bernier, et al.
The Journal of Biological Chemistry|April 1, 2006
Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1Fernand Gobeil, Tang Zhu, Sonia Brault, et al.
Mediators of Inflammation|January 24, 2014
Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammationEsther Rodríguez-Gallego, Marta Riera-Borrull, Anna Hernández-Aguilera, et al.
ACS Synthetic Biology|January 12, 2021
Mutation Maker, An Open Source Oligo Design Platform for Protein EngineeringKaori Hiraga, Petr Mejzlik, Matej Marcisin, et al.
Frontiers in Chemistry|March 18, 2022
Relative Populations and IR Spectra of Cu<sub>38</sub> Cluster at Finite Temperature Based on DFT and Statistical Thermodynamics CalculationsCarlos Emiliano Buelna-García, Cesar Castillo-Quevedo, Jesus Manuel Quiroz-Castillo, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 7, 2013
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cellsSílvia Cufí, Rosa Bonavia, Alejandro Vazquez-Martin, et al.
The Journal of Biological Chemistry|July 9, 2003
Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1Fernand Gobeil, Sylvie G Bernier, Alejandro Vazquez-Tello, et al.
Circulation Research|April 6, 2002
Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptorsFernand Gobeil, Isabelle Dumont, Anne Marilise Marrache, et al.
International Journal of Oncology|August 12, 2011
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line modelsCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Bernardo Queralt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptorA Marilise Marrache, Fernand Gobeil, Sylvie G Bernier, et al.
Advances in Experimental Medicine and Biology|May 20, 2003
Platelet activating factor receptorsA Marilise Marrache, Fernand Gobeil, Sylvie G Bernier, et al.
The Journal of Biological Chemistry|April 1, 2006
Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1Fernand Gobeil, Tang Zhu, Sonia Brault, et al.
Mediators of Inflammation|January 24, 2014
Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammationEsther Rodríguez-Gallego, Marta Riera-Borrull, Anna Hernández-Aguilera, et al.
ACS Synthetic Biology|January 12, 2021
Mutation Maker, An Open Source Oligo Design Platform for Protein EngineeringKaori Hiraga, Petr Mejzlik, Matej Marcisin, et al.
Frontiers in Chemistry|March 18, 2022
Relative Populations and IR Spectra of Cu<sub>38</sub> Cluster at Finite Temperature Based on DFT and Statistical Thermodynamics CalculationsCarlos Emiliano Buelna-García, Cesar Castillo-Quevedo, Jesus Manuel Quiroz-Castillo, et al.
Pageof 18